- Recommendation ID
- NG191/13
- Question
What are the views, preferences and experiences of people with COVID-19-associated pulmonary aspergillosis (CAPA), and their families or carers, on:
• available tests for diagnosing CAPA
• available treatments for CAPA?- Any explanatory notes
(if applicable) P: people who have been diagnosed with and treated for CAPA, and their families or carers. Subgroups of particular interest include young people and children, and pregnant women.
I: tests for diagnosing CAPA and treatments for CAPA.
C: people who have been diagnosed with, and had treatment for, CAPA in hospital.
Source guidance details
- Comes from guidance
- COVID-19 rapid guideline: managing COVID-19
- Number
- NG191
- Date issued
- March 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 17/12/2021 |